K-V Pharmaceutical Company ("KV") announced that its plan of reorganization (the "Plan") has become effective and that it has successfully emerged from chapter 11 with significantly reduced debt and a $375 million recapitalization. Pursuant to the...
Read Story
September 17, 2013, 07:35 AM
|
K-V Pharmaceutical Company announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the company's settlement agreement with Hologic, Inc., and authorized the Company to...
Read Story
January 02, 2013, 07:33 AM
|
K-V Pharmaceutical Company received a commitment from lenders led by an affiliate of Silver Point Finance LLC for $85 million in senior secured post-petition debtor-in-possession financing, which the company intends to use to, among other things...
Read Story
December 13, 2012, 07:07 AM
|